AKT2 Human siRNA Oligo Duplex (Locus ID 208)

SKU SR300144

AKT2 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each

Product Data

• Purity: HPLC purified
• Quality Control: Tested by ESI-MS
• Sequences: Available with shipment
• Components:
  AKT2 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each (Locus ID 208); Included - SR30004, Trilencer-27 Universal Scrambled Negative Control siRNA Duplex - 2 nmol; Included - SR30005, RNAse free siRNA Duplex Resuspension Buffer - 2 ml

  Once you identified the best-performing siRNA sequence of the kit, you can order a single siRNA individually.

  Cat#	SRXXXXXX followed by A, B or C, then add L; For example, for sequence A of SR300003, the SKU is SR300003AL.
  Description	10 nmol of siRNA of the above specified vial, scramble control NOT included
  Price	$/€ 375 per vial

  If you want to order 20 nmol, please order quantity of 2 units.; If you need negative control, please order SR30004 (2 nmol of scramble siRNA control)
  Need an individual siRNA?
• Stability: One year from date of shipment when stored at -20°C.
• Shipping: Ambient
• # of Transfections: Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM).
• Note: Single siRNA duplex (10nmol) can be ordered.

Reference Data

• RefSeq: NM_001243027, NM_001243028, NM_001330511, NM_001626
• UniProt ID: P31751
• Synonyms: HIHGHH; PKBB; PKBBETA; PRKBB; RAC-BETA
• Summary: This gene is a putative oncogene encoding a protein belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains, which is involved in signaling pathways. The gene serves as an oncogene in the tumorigenesis of cancer cells For example, its overexpression contributes to the malignant phenotype of a subset of human ductal pancreatic cancers. The encoded protein is a general protein kinase capable of phophorylating several known proteins, and has also been implicated in insulin signaling. [provided by RefSeq, Nov 2019]
• Performance Guaranteed: OriGene guarantees that at least two of the three Dicer-Substrate duplexes in the kit will provide at least 70% or more knockdown of the target mRNA when used at 10 nM concentration by quantitative RT-PCR when the TYE-563 fluorescent transfection control duplex (cat# SR30002) indicates that >90% of the cells have been transfected and the HPRT positive control (cat# SR30003) provides 90% knockdown efficiency.; ; For non-conforming siRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the siRNA kit. To arrange for a free replacement with newly designed duplexes, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled siRNA control (quantitative RT-PCR data required).